Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
NewAmsterdam Pharma Co N.V. market cap for the quarter ending 2026-08-03 was $3.28B, a 33.77% increase year-over-year.
NewAmsterdam Pharma Co N.V. market cap for the quarter ending 2026-06-30 was $3.99B, a 95.59% increase year-over-year.
NewAmsterdam Pharma Co N.V. market cap for the quarter ending 2026-04-29 was $3.32B, a 47.69% increase year-over-year.
NewAmsterdam Pharma Co N.V. market cap for the quarter ending 2026-03-31 was $3.73B, a 62.56% increase year-over-year.
NewAmsterdam Pharma Co N.V. market cap for fiscal 2026 was $3.28B.
NewAmsterdam Pharma Co N.V. market cap for fiscal 2025 was $4.02B, a 44.62% increase from fiscal 2024.
NewAmsterdam Pharma Co N.V. market cap for fiscal 2024 was $2.78B, a 201.49% increase from fiscal 2023.
NewAmsterdam Pharma Co N.V. market cap for fiscal 2023 was $921.19M, a 3.62% increase from fiscal 2022.